Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
about
Treatment of immune thrombocytopenic purpura: focus on eltrombopag.Use of rituximab in the treatment of refractory systemic lupus erythematosus: Singapore experience.Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cellsSuccessful treatment with thrombopoietin receptor agonist in avoiding splenectomy for patients with chronic refractory immune thrombocytopeniaRituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura.Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.Rituximab-induced serum sickness in refractory immune thrombocytopenic purpura.Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy.Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study.Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.Drug-induced thrombocytopenia secondary to natalizumab treatmentA multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases.Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases--lessons from B cell-depletion therapy.Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.Management of immune thrombocytopoenia in a patient with newly-diagnosed smouldering myeloma and colorectal cancer.Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.Clinical Practice Updates in the Management Of Immune Thrombocytopenia.
P2860
Q33385976-84E5F591-EBC3-415C-BC88-FF126398BF80Q33388044-9D3D0AF2-945C-4C2E-9A5D-3A7EB2A803B8Q33395970-C1135805-1A19-4728-8F72-148AF0744902Q33399821-9CA8EFDC-9804-44DE-9EB2-D980F9B16B42Q33400324-C65902AF-E12B-4A2F-A37E-055ECFED76F3Q33401100-000388F4-63EE-46D4-8C39-A06BC06CE398Q33401321-35C2825F-F2A4-41DA-8395-AF800DED6314Q33401898-6D53C17D-BCDD-4A46-A91E-B58A01D4CB6AQ33402069-59C42E22-B18B-447C-916E-D9FCA612FF2AQ33402763-A18453C0-2174-4A75-9AF5-66E3E7CD6087Q33408915-2DFE09FF-1B72-4CED-9991-95C233B6D71CQ33410348-81B6D10B-A9D6-4A7E-B2E8-E7EE2B391D6BQ33415628-991000F9-4535-405F-BC47-D345C8E85328Q33416569-6127D0CE-A07B-4090-9E4F-1B90F943A2D8Q33429426-DFCC2164-680B-4A8E-A206-F8FFB0A291B8Q33431689-B2C1830B-2E4A-4E9B-ACD5-5495065204E3Q37552019-7BB1F99A-C44A-4F87-97DD-CCEA4B3483D8Q37843939-F4A03F1B-1E43-4615-8857-35B580AE7DB7Q41851571-646961BE-AFE9-412A-9CC4-ACE425EDBB8FQ42694850-277CF03A-DF47-40FB-BCF6-CE1A1A02F932Q47161464-0D1D1F7D-86F4-4AF3-8408-B41ACDB3C235
P2860
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Rituximab therapy in adult pat ...... : long-term follow-up results.
@ast
Rituximab therapy in adult pat ...... : long-term follow-up results.
@en
type
label
Rituximab therapy in adult pat ...... : long-term follow-up results.
@ast
Rituximab therapy in adult pat ...... : long-term follow-up results.
@en
prefLabel
Rituximab therapy in adult pat ...... : long-term follow-up results.
@ast
Rituximab therapy in adult pat ...... : long-term follow-up results.
@en
P2093
P1476
Rituximab therapy in adult pat ...... : long-term follow-up results.
@en
P2093
Franca Soldano
Francesca Patriarca
Francesco Zaja
Marta Battista
Marta Medeot
Miriam Isola
Nicola Vianelli
Renato Fanin
Stefano De Luca
P304
P356
10.1111/J.1600-0609.2008.01100.X
P577
2008-05-27T00:00:00Z